M James Barrett's Net Worth
M James Barrett's net worth is estimated to be at least $57,365,033.08 as of 04/27/2024. CoreStreet's estimation of M James Barrett's net worth is based on their sale of stock and current holding of stock.
M James Barrett is Director at GlycoMimetics Inc. They have executed at least 16 trades of stock as per SEC Form 4 filings. Their most recent trade was for 9,539 units of GLYC stock on 05/10/2018. Their biggest sale was on 11/27/2017 when they sold 569,620 units of Appian Corp stock for $11,101,893.80. They typically trade 2 times per year.
Total value of insider buys:
- $35,999,920.00
Total value of insider sells:
- $21,365,113.08
Most recent insider trade:
- May 10, 2018
M James Barrett's Insider Trading History
| GlycoMimetics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 10, 2018 | Director | 9,539 | $17.81 | Sell | $169,889.59 |
Jan. 15, 2014 | Director | 1,000,000 | $8.00 | Buy | $8,000,000.00 |
| Appian Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 27, 2017 | Major Shareholder | 569,620 | $19.49 | Sell | $11,101,893.80 |
| Mersana Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 3, 2017 | Major Shareholder | 1,000,000 | $15.00 | Buy | $15,000,000.00 |
| Zosano Pharma Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 29, 2016 | Major Shareholder | 50,000 | $1.01 | Sell | $50,500.00 |
| Supernus Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 8, 2015 | Director | 212,970 | $14.56 | Sell | $3,100,843.20 |
Nov. 25, 2015 | Director | 16,179 | $16.35 | Sell | $264,526.65 |
Nov. 18, 2015 | Director | 93,000 | $16.61 | Sell | $1,544,730.00 |
Nov. 16, 2015 | Director | 119,650 | $16.24 | Sell | $1,943,116.00 |
June 17, 2015 | Director | 111,881 | $16.39 | Sell | $1,833,729.59 |
June 16, 2015 | Director | 55,105 | $16.85 | Sell | $928,519.25 |
| Clovis Oncology Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 15, 2015 | Director | 2,424 | $92.43 | Sell | $224,050.32 |
June 4, 2013 | Director | 2,483 | $70.80 | Sell | $175,796.40 |
| TRACON Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 4, 2015 | Major Shareholder | 500,000 | $10.00 | Buy | $5,000,000.00 |
| Catalyst Biosciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 21, 2013 | major shareholder | 5,333 | $5.16 | Sell | $27,518.28 |
| Epizyme Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 15, 2013 | major shareholder | 406,500 | $19.68 | Buy | $7,999,920.00 |